Accession | ARO:3007666 |
Definition | Candida spp. cyp51A1 is a fungal cytochrome P450 enzyme with mutations in the gene causing triazole and imidazole resistance. |
AMR Gene Family | triazole-resistant fungal cytochrome P450 enzyme, imidazole-resistant fungal cytochrome P450 enzyme |
Drug Class | imidazole antibiotic, triazole antibiotic |
Resistance Mechanism | antibiotic target alteration |
Classification | 11 ontology terms | Show + process or component of antibiotic biology or chemistry + mechanism of antibiotic resistance + antibiotic target alteration [Resistance Mechanism] + mutation conferring antibiotic resistance + determinant of antibiotic resistance + antibiotic molecule + azole antibiotic + antibiotic resistant gene variant or mutant + antifungal-resistant cytochrome P450 enzyme + imidazole antibiotic [Drug Class] + triazole antibiotic [Drug Class] |
Parent Term(s) | 5 ontology terms | Show + confers_resistance_to_antibiotic fluconazole [Antibiotic] + confers_resistance_to_antibiotic itraconazole [Antibiotic] + confers_resistance_to_antibiotic ketoconazole [Antibiotic] + triazole-resistant fungal cytochrome P450 enzyme [AMR Gene Family] + imidazole-resistant fungal cytochrome P450 enzyme [AMR Gene Family] |
Publications | Sanglard D, et al. 1998. Antimicrob Agents Chemother 42(2):241-53 Amino acid substitutions in the cytochrome P-450 lanosterol 14alpha-demethylase (CYP51A1) from azole-resistant Candida albicans clinical isolates contribute to resistance to azole antifungal agents. (PMID 9527767) |